This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monday's Small-Cap Winners and Losers

Star Scientific (STSI) was plunging 32.4% after the Chester, Va., company lost its patent infringement case against R.J. Reynolds Tobacco regarding a process that cures tobacco without creating carcinogens.

The U.S. District Court for the District of Maryland granted summary judgment in favor of R.J. Reynolds, calling Star's claims invalid due to a "fatally indefinite" term in one of the patents-in-suit describing the conditions under which the tobacco must be cured. Star proclaimed its intent to appeal the decision. Its shares were falling 55 cents to $1.15. Shares of R.J. Reynolds' parent, Reynolds American (RAI), were up 51 cents, or 0.8%, to $64.27.

Analex (NLX), which sells software and related services to U.S. government agencies, nearly doubled on word that Britain's QinetiQ will buy it for $3.70 a share -- a hefty premium to its $1.91 closing price Friday. The Fairfax, Va.-based company was up $1.74 to $3.62.

Futuremedia (FMDAD) surged after the Britain-based communications company said it would continue to be listed on the Nasdaq, having officially regained compliance with the exchange's $1-a-share minimum bid price requirement. Shares were rising 93 cents, or 39.9%, to $3.26.

e-Future Information Technology (EFUT - Get Report) announced it will develop a supply-chain-management platform for health care products giant Johnson & Johnson's (JNJ) Chinese subsidiary. Terms weren't disclosed. China-based e-Future was up $6.59, or 21%, to $38. Johnson & Johnson was slipping 45 cents to $67.31.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ENA $0.00 0.00%
STSI $0.21 3.14%
EFUT $4.33 0.46%
PETS $16.29 -0.55%
AAPL $109.68 -1.50%


Chart of I:DJI
DOW 16,825.87 +35.68 0.21%
S&P 500 1,984.28 +4.36 0.22%
NASDAQ 4,751.9330 +3.5720 0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs